DrugsControl Media Services

News Detail

US FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot (15-06-2024)

Washington, 15 June 2024 (Reuters) The U.S. health regulator has changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to target the KP.2 variant, if feasible, instead of the JN.1 lineage it sought to targe......
View Details

Source : Reuters
KP.2 variant COVID-19 vaccines JN.1 lineage Food and Drug Administration Novavax Moderna

Related News